1. Home
  2. FCNCP vs HLN Comparison

FCNCP vs HLN Comparison

Compare FCNCP & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Citizens BancShares Inc.

FCNCP

First Citizens BancShares Inc.

HOLD

Current Price

$21.27

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.97

Market Cap

43.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCNCP
HLN
Founded
N/A
2022
Country
United States
United Kingdom
Employees
18141
N/A
Industry
Major Banks
Package Goods/Cosmetics
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
43.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FCNCP
HLN
Price
$21.27
$9.97
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
15.3K
8.1M
Earning Date
N/A
02-26-2026
Dividend Yield
N/A
1.81%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.04
Revenue Next Year
N/A
$4.58
P/E Ratio
N/A
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$19.30
$8.71
52 Week High
$22.86
$11.42

Technical Indicators

Market Signals
Indicator
FCNCP
HLN
Relative Strength Index (RSI) 48.69 42.58
Support Level $20.80 $9.60
Resistance Level $21.33 $10.00
Average True Range (ATR) 0.26 0.15
MACD -0.01 -0.02
Stochastic Oscillator 67.74 30.30

Price Performance

Historical Comparison
FCNCP
HLN

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc. is a Raleigh, N.C.-based financial holding company operating through its subsidiary, First-Citizens Bank & Trust Company. It provides comprehensive retail banking, commercial lending, leasing, and wealth management services via a nationwide branch network and digital platforms. In 2023 acquisition of Silicon Valley Bank, it also specializes in banking for tech, healthcare, and innovation firms.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: